Momelotinib vs. ruxolitinib in myelofibrosis patient subgroups by baseline hemoglobin levels in the SIMPLIFY-1 trial
| dc.contributor.author | Gupta, Vikas | |
| dc.contributor.author | Oh, Stephen T. | |
| dc.contributor.author | Devos, Timothy | |
| dc.contributor.author | Dubruille, Viviane | |
| dc.contributor.author | Catalano, John | |
| dc.contributor.author | Somervaille, Tim C. P. | |
| dc.contributor.author | Platzbecker, Uwe | |
| dc.contributor.author | Giraldo, Pilar | |
| dc.contributor.author | Kosugi, Hiroshi | |
| dc.contributor.author | Sacha, Tomasz | |
| dc.contributor.author | Mayer, Jiri | |
| dc.contributor.author | Illés, Árpád | |
| dc.contributor.author | Ellis, Catherine | |
| dc.contributor.author | Wang, Zhaohui | |
| dc.contributor.author | Gonzalez Carreras, Francisco J. | |
| dc.contributor.author | Strouse, Bryan | |
| dc.contributor.author | Mesa, Ruben | |
| dc.date.accessioned | 2024-07-24T10:58:31Z | |
| dc.date.available | 2024-07-24T10:58:31Z | |
| dc.date.issued | 2024 | |
| dc.date.oa | 2025-01-31 | |
| dc.date.pasync | 2024-08-06T23:07:58Z | |
| dc.date.updated | 2024-07-24T10:58:31Z | |
| dc.description.corrector | LB | |
| dc.identifier.citation | Leukemia & Lymphoma. -65 : 7 (2024), p. 965-977. -Leuk. Lymphoma. - 1042-8194 | |
| dc.identifier.doi | http://dx.doi.org/10.1080/10428194.2024.2328800 | |
| dc.identifier.issn | 1042-8194 | |
| dc.identifier.opac | https://ebib.lib.unideb.hu/ebib/CorvinaWeb?action=cclfind&resultview=long&ccltext=idno+BIBFORM122925 | |
| dc.identifier.scopus | 85188511469 | |
| dc.identifier.uri | https://hdl.handle.net/2437/377072 | |
| dc.identifier.url | https://www.tandfonline.com/doi/full/10.1080/10428194.2024.2328800 | |
| dc.identifier.wos | 001187585300001 | |
| dc.language | eng | |
| dc.rights.access | open access article | |
| dc.rights.owner | szerzők | |
| dc.subject.mab | Orvostudományok | |
| dc.subject.mab | Klinikai orvostudományok | |
| dc.title | Momelotinib vs. ruxolitinib in myelofibrosis patient subgroups by baseline hemoglobin levels in the SIMPLIFY-1 trial | |
| dc.type | folyóiratcikk | |
| dc.type | idegen nyelvű folyóiratközlemény külföldi lapban |
Fájlok
Eredeti köteg (ORIGINAL bundle)
1 - 1 (Összesen 1)
Nincs kép
- Név:
- FILE_UP_0_Momelotinib vs. ruxolitinib in myelofibrosis patient subgroups by baseline hemoglobin levels in the SIMPLIFY-1 trial.pdf
- Méret:
- 5.16 MB
- Formátum:
- Adobe Portable Document Format
- Leírás:
- Kiadói változat